Detection of Methylene Tetrahydrofolate Reductase Gene Polymorphism (C677T) In Sudanese Patients with Chronic Myeloid Leukemia

  • Negood Abdelhameed Osman Faculty of Medical Laboratory Sciences, National University, Sudan
  • Alsadig Gassoum National Center of Neurological Sciences, Sudan
  • Sanabel Alhussien Ahmed National Center of Neurological Sciences, Sudan
  • Nihad Elsadig Babiker National Center of Neurological Sciences, Sudan

Abstract

Chronic myeloid leukaemia (CML) is a kind of cancer that affects the white blood cells and resort to progress slowly through many years. It’s occur at any age, but is most common in older (60-65 years) of age. This is a cross sectional study aimed to detect MTHFR gene polymorphism (C677T) among Sudanese patients diagnosed with Chronic Myeloid Leukaemia and conducted at the research laboratory of the national center of neurological sciences (NCNS), Khartoum, Sudan.50 patients with Chronic Myeloid Leukemia (CML) diagnosed as BCR-ABL positive by RT-PCR used as a cases and 50 apparently healthy individuals as a control. A 5 ml of blood samples were collected in EDTA anticoagulant container for DNA Extraction and white blood cells count, hemoglobin level and platelets count. Genotyping of the MTHFR was carried out using PCR technique and the SNP (C677T) confirmed by sequencing a subset of samples. The results were analyzed using bioinformatics tools. The results showed; the most affected age group in the patients was 51-60 years followed by 41-50 years which constituted 32% and 30%, respectively. The hematological findings revealed that, the mean of TWBCs was 47.4, HB was 11.9 for patients, 7.2 and 14.1 respectively for control group (P = 0.000). PLT was 313.5 for patients and 287.5 for control group (P = 0.187). MTHFR gene was detected in the all patients (198pb) by the PCR, Sequence results were aligned with the reference sequence of MTHFR gene, the polymorphic C >T was found to be matched with the registered mutation in NCBI data base. This study provides the first evidence for associations of MTHFR gene polymorphism with the risk of chronic myeloid leukemia in Sudanese patients. The C >T genotype of the rs 677 polymorphism in MTHFR gene may have a promoting effect on chronic myeloid leukemia.


Keywords: Chronic myeloid leukaemia (CML), DNA, PCR, RT-PCR, MTHFR

Downloads

Download data is not yet available.

Author Biographies

Negood Abdelhameed Osman, Faculty of Medical Laboratory Sciences, National University, Sudan

Faculty of Medical Laboratory Sciences, National University, Sudan

Alsadig Gassoum, National Center of Neurological Sciences, Sudan

National Center of Neurological Sciences, Sudan

Sanabel Alhussien Ahmed, National Center of Neurological Sciences, Sudan

National Center of Neurological Sciences, Sudan

Nihad Elsadig Babiker, National Center of Neurological Sciences, Sudan

1 Faculty of Medical Laboratory Sciences, National University, Sudan

2 National Center of Neurological Sciences, Sudan

3 Darfur University College, Sudan

References

1- Greaves M.F. Etiology of acute leukemia. Lancet 1997; 349: 344-49.
2- Hehlmann R., et al. Chronic myeloid leukemia. The Lancet 2007; 370: 342-350
3- Skibola C.F., Smith M.T., Kane E., Roman E., Rollin¬son S., Cartwright R.A., Morgan G. Polymor¬phisms in the methylenetetrahydrofolate re¬ductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci U S A 1999; 96: 12810-15
4- Cortes J. CML: Living with a chronic disease. Teleconference of The Leukemia &Lymphoma Society, Past Patient Education Programs, Leukemia. April 17, 2013.www.lls.org/#/resourcecenter/pastprograms/leukemia/041713_cml. Accessed September 10, 2014.
5- GLOBOCAN. Estimated Cancer Incidence, Mortality and Prevalence Worldwide 2012. www.globocan.iarc.fr. Accessed 21 September 2014.
6- Cortes J., Kantarjian H. How I treat newly diagnosed chronic phase CML. Blood 2012; 120(7):1390-1397.
7- Lordelo G.S., Miranda A.L., Vilela1 A.K. Akimoto P.Z., Alves C.O., Hiragi1 A., Nonino et al. reductase and glutathione S-transferase M1 gene polymorphisms and chronic myeloid leukemia in a Brazilian population. Gen and Mol Res 2012; (1): 1013-1026
8- Robien K., Ulrich C.M. 5, 10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE mini review. Am j Epidemiol. 2003; 157(7):571- 582.
9- Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P. A candidate genetic risk factor for vascular disease: a com¬mon mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-13.
10- Andolina J., Neudorf S., Corey S. How I treat childhood CML. Blood. 2012; 119(8):1821-1830.
11- Ya-Zhen Qin M.S., Qian Jiang M.D., Hao Jiang M.M.S., Yue-Yun Lai M.D., Hong-Hu Zhu M.D., Yan-Rong Liu M.S,, et al . Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients. Medicine _2016; 95(2):1-9
12- Karmakar S., Banerjee D., Chakrabarti A. Platelet Proteomics in Chronic Myeloid Leukemia. Int J Blood Dis Dis. 2017; 1(1): 001-006.
13- Ueland P.M., Hustad S., Schneede J., Refsum H., Vollset S.E. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci. 2001; 22(4):195-201.
14- Botto L.D., Yang Q. 5, 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000; 151(9):862-877
15- Hur M., Park J.Y., Cho H.C., Lee K.M., Shin H..Y, Cho H.I. Methylenetetrahydrofolate reductase A1298C genotypes are associated with the risks of acute lymphoblastic leukaemia and chronic myelogenous leukaemia in the Korean population. Clin Lab Haematol. 2006; 28(3):154-159.
16- Duthie S.J., Narayanan S., Brand G.M., Pirie L., et al. Impact of folate deficiency on DNA stability. J. Nutr2002; 132: 2444S-2449S
17- Moon H.W., Kim T.Y., Oh B.R., et al. MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case-control study in Korea. Leuk Res. 2007; 31(9):1213 1217.
Statistics
43 Views | 62 Downloads
How to Cite
Osman, N. A., Gassoum, A., Ahmed, S. A., & Babiker, N. (2019). Detection of Methylene Tetrahydrofolate Reductase Gene Polymorphism (C677T) In Sudanese Patients with Chronic Myeloid Leukemia. Journal of Drug Delivery and Therapeutics, 9(6), 162-168. https://doi.org/10.22270/jddt.v9i6.3693